In vitro and in vivo activities of posaconazole against Coccidioides immitis. - sprookjes - yvandenbroek - TriplyDB

In vitro and in vivo activities of posaconazole against Coccidioides immitis.

In vitro and in vivo activities of posaconazole against Coccidioides immitis.

http://www.wikidata.org/entity/Q34107135

about

Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.Effects of age, gender, and race/ethnicity on the pharmacokinetics of posaconazole in healthy volunteers.Posaconazole plasma concentrations in juvenile patients with invasive fungal infection.Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults.Posaconazole: clinical pharmacology and potential for management of fungal infections.Activity of posaconazole in the treatment of central nervous system fungal infections.Pharmacokinetics of posaconazole coadministered with antacid in fasting or nonfasting healthy men Newer triazole antifungal agents: pharmacology, spectrum, clinical efficacy and limitations.Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections.Experimental animal models of coccidioidomycosis.Posaconazole: a new broad-spectrum antifungal agent.Activity of posaconazole in treatment of experimental disseminated zygomycosis.Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent.Intrapulmonary pharmacokinetics and pharmacodynamics of itraconazole and 14-hydroxyitraconazole at steady state.Use of posaconazole in the treatment of invasive fungal infections.Disposition of posaconazole following single-dose oral administration in healthy subjects.Posaconazole: a next-generation triazole antifungal.Posaconazole: An Update of Its Clinical Use.Therapeutic efficacy of posaconazole against Candida glabrata in a murine model of vaginitis.Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections.Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection.Posaconazole therapy for systemic coccidioidomycosis in a chimpanzee (Pan troglodytes): a case report.

P2860

Q28675835-7FFE3623-883A-4C22-B162-515D09B8BA8A Q34680661-61A3A314-75D4-4D5E-80E3-F686AD14380E Q35635971-44002E4E-F7A9-4E04-B256-3F8AC73B2392 Q35647678-798BD317-5F1D-4F7E-933F-E26926DB4633 Q35685548-CD84CA0A-3897-41AF-AB07-4E51A4FC8E8B Q35825919-D90080F3-A179-4AD1-BB06-6F5ABC38EB89 Q36233491-53F40D60-FCA4-462F-88F1-D2DA1BC0DC5F Q36246196-37169C46-62FD-40CB-A950-E2FEAAD6BB62 Q36489989-B3A2B248-4402-49C6-87CC-A3B306E9E7CB Q36491819-132F1AB6-E3CE-4DCF-83C9-10DEA0490D46 Q36589297-0C85BB2F-0323-485C-AA3E-EF8A37529CAB Q36754015-431DAE47-9229-4DED-9B0A-FAB7A6583A47 Q36828159-DC46E90E-5F27-4CE0-A423-44670D835A88 Q36880761-E20C74D3-D7CA-4E07-BBD0-E0B643F9A18B Q37055215-EBC8CB10-ED87-4671-988D-4361F764BAE4 Q37568382-F1E4B11F-00A7-43A0-9814-7C5B68E26F05 Q37810083-E5800041-7E55-47A0-8D11-C89001F10662 Q39955617-92B494C3-6773-47E2-9E20-24B0E1E5DB45 Q40188974-BA0B1551-BB06-4426-939D-D8C722A00419 Q42144246-7BC01497-15D1-47D3-B620-BA4147D11DE4 Q43265503-83B47F86-B3FF-48BC-B8B5-429C54C9B04D Q45261117-967D6956-3DA4-4545-B042-E543D85ACABB Q46486677-7DA053F9-1E62-4100-8C59-E53757DC3AD9 Q46785739-C78B6E60-4F20-4D28-828F-08C3F6394E03

P2860

In vitro and in vivo activities of posaconazole against Coccidioides immitis.

http://www.wikidata.org/entity/Q34107135

description

2002 nî lūn-bûn

@nan

2002 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

In vitro and in vivo activities of posaconazole against Coccidioides immitis.

@ast

In vitro and in vivo activities of posaconazole against Coccidioides immitis.

@en

In vitro and in vivo activities of posaconazole against Coccidioides immitis.

@nl

type

label

In vitro and in vivo activities of posaconazole against Coccidioides immitis.

@ast

In vitro and in vivo activities of posaconazole against Coccidioides immitis.

@en

In vitro and in vivo activities of posaconazole against Coccidioides immitis.

@nl

prefLabel

In vitro and in vivo activities of posaconazole against Coccidioides immitis.

@ast

In vitro and in vivo activities of posaconazole against Coccidioides immitis.

@en

In vitro and in vivo activities of posaconazole against Coccidioides immitis.

@nl

P1433

Q34107135-97220EB7-72D8-40ED-9362-0B735116AD4D

P1476

Q34107135-8C9735A2-DFC1-4FA9-A955-466874034BE8

P2093

Q34107135-07B73A4D-9090-4D6A-9532-8F4A39162809

Q34107135-128ECFD6-B43B-47EB-BDD7-B09AC0401A7B

Q34107135-150B9DF1-E052-46B4-8EE3-2D0929D80ED8

Q34107135-2B888223-4960-44E7-8EB9-A7BDC6BDECB0

Q34107135-AB668237-75E7-4C70-B230-BF6DE8D638F8

Q34107135-D190AD7F-C466-48A0-ACEB-567004F89C2F

Q34107135-EEA1C030-A4B1-4214-B599-24159547350F

P2860

Q34107135-034CB3F7-5765-4EAB-B18E-07CE196B877B

Q34107135-08EC7F2B-ACBB-442A-B0A7-FF7FEF06C126

Q34107135-220F1199-043C-4CB1-9EC3-61C42684B9F0

Q34107135-25E8B7EB-B280-4275-B21F-92E5AC224E1C

Q34107135-450EBE7B-0760-4F97-AD17-800DA2683B0D

Q34107135-47D9E7EC-95BE-4401-BB00-BC2D967B36FD

Q34107135-4847B6D3-2E90-4441-9CF2-256BA1777A9C

Q34107135-4E1296C1-D40F-4DFC-83C5-BD5656678BC9

Q34107135-505722FE-1DBD-40D7-9E14-E8202E1828BA

Q34107135-6681E142-A54F-4951-9BFA-2071CE3E0C13

P304

Q34107135-9D7DA51D-65A1-434C-B9DD-018331A80CBE

P31

Q34107135-44473807-A430-45B9-BC25-230B5E29B5BB

P356

Q34107135-EA734B4D-E7C6-41E8-891B-02EF987295B0

P407

Q34107135-4F6FF507-645F-4F6A-B97B-BC82520F9FD2

P433

Q34107135-DA786024-56A8-45EE-B7C4-7993F21DD594

P478

Q34107135-A0D5A873-FB99-4398-8E9C-0337DB28C730

P577

Q34107135-9C45900E-14CC-4683-A5C0-BA4C40E6A8E8

P5875

Q34107135-6CF2A453-D004-4F8E-A333-BED84520D400

P698

Q34107135-ECE339B1-E4DB-4A31-B306-52B4CD71C378

P932

Q34107135-27B1DD9B-F5B8-47FD-A296-FB62F4B74ED5

P356

AAC.46.5.1352-1356.2002

P1433

Antimicrobial Agents and Chemotherapy

P1476

In vitro and in vivo activities of posaconazole against Coccidioides immitis.

@en

P2093

David Loebenberg

http://www.w3.org/2001/XMLSchema#string

Gloria M González

http://www.w3.org/2001/XMLSchema#string

John R Graybill

http://www.w3.org/2001/XMLSchema#string

Laura K Najvar

http://www.w3.org/2001/XMLSchema#string

Michael Rinaldi

http://www.w3.org/2001/XMLSchema#string

Rolando Tijerina

http://www.w3.org/2001/XMLSchema#string

Rosie Bocanegra

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans

In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts

Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae

Comparison of a new triazole antifungal agent, Schering 56592, with itraconazole and amphotericin B for treatment of histoplasmosis in immunocompetent mice.

Efficacy of SCH56592 in a rabbit model of invasive aspergillosis.

SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum ("Ramichloridium mackenziei")

Amphotericin B: 30 years of clinical experience.

In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis.

In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp.

Activity of the triazole SCH 56592 against disseminated murine coccidioidomycosis.

P304

1352-1356

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.46.5.1352-1356.2002

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11407019

http://www.w3.org/2001/XMLSchema#string

P698

11959568

http://www.w3.org/2001/XMLSchema#string

P932

127157

http://www.w3.org/2001/XMLSchema#string